![Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound](/docs/US/2020-03-03/US10576073B2/abs.jpg.600x600.jpg)
- 专利标题： Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
-
申请号： US16244956申请日： 2019-01-10
-
公开(公告)号： US10576073B2公开(公告)日： 2020-03-03
- 发明人: Lori Jean Patterson , Robert S. Chao , Miroslav Rapta
- 申请人： THERAVANCE BIOPHARMA R&D IP, LLC
- 申请人地址： US CA South San Francisco
- 专利权人： Theravance Biopharma R&D IP, LLC
- 当前专利权人： Theravance Biopharma R&D IP, LLC
- 当前专利权人地址： US CA South San Francisco
- 代理商 Jeffrey A. Hagenah
- 主分类号： A61K31/4465
- IPC分类号： A61K31/4465 ; C07D211/22 ; C07D211/32
![Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound](/abs-image/US/2020/03/03/US10576073B2/abs.jpg.150x150.jpg)
摘要：
The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases.
公开/授权文献
信息查询
IPC分类:
